The Zhitong Finance App learned that before the US stock market on Tuesday, Johnson & Johnson (JNJ.US) announced better-than-expected results for the third quarter of 2026 and raised revenue and profit guidelines for the full year 2026. Financial reports show that Johnson & Johnson's third-quarter sales increased 5.9% year over year to US$25.4 billion, in line with general market expectations. In terms of profit, GAAP net profit plummeted 95.9% year over year to US$210 million. After dilution, earnings per share were only 0.09 US dollars (2.12 US dollars in the same period last year), mainly due to one-time pre-tax expenses related to the proposed settlement of the US$5,519 billion talc lawsuit.

The Zhitong Finance App learned that before the US stock market on Tuesday, Johnson & Johnson (JNJ.US) announced better-than-expected results for the third quarter of 2026 and raised revenue and profit guidelines for the full year 2026. Financial reports show that Johnson & Johnson's third-quarter sales increased 5.9% year over year to US$25.4 billion, in line with general market expectations. In terms of profit, GAAP net profit plummeted 95.9% year over year to US$210 million. After dilution, earnings per share were only 0.09 US dollars (2.12 US dollars in the same period last year), mainly due to one-time pre-tax expenses related to the proposed settlement of the US$5,519 billion talc lawsuit.